Dr. Kinnari Arte, currently a scientist with AstraZeneca, has successfully defended her Ph.D. Thesis. Kinnari studied spray freeze drying of mRNA lipid nanoparticle vaccines: ‘Understanding the Impact of Spray Freeze Drying on RNA/LNP Formulations’ as a CPPR student under the mentorship of Dr. Qi (Tony) Zhou, CPPR Assistant Site Director at Purdue University. Congratulations on this milestone achievement!
Dr. Qi (Tony) Zhou has been approved by the Purdue Board of Trustees as a Full Professor of Industrial and Molecular Pharmaceutics. Tony is the Assistant Site Director for CPPR at Purdue. We congratulate him on this well-deserved accomplishment!
Dr. Xiuling Lu, CPPR faculty and Professor of Pharmaceutics at UConn School of Pharmacy, has been inducted into the CT Academy of Science and Engineering (CASE). Dr. Lu is working to develop new drug delivery systems and improving manufacturing processes. She joins CPPR faculty, Dr. Bodhi Chaudhuri, who was inducted in 2024. Read more here: UConn’s Influence on CASE: Research Contributions, Policy Impact, and Future Trends in Connecticut – Forward Pathway
AbbVie joins Alexion, Alkermes, Astrazeneca, ATS Scientific Products, Boehringer-Ingelhiem, Gilead, Glaxosmithkline, Lilly, Otsuka, Roquette, and Sanofi on the CPPR Industrial Advisory Board. We look forward to AbbVie’s participation in our quest to advance pharmaceutical processing. The funds that AbbVie has committed to CPPR research are pooled with those of the other member companies. The funds support rigorous academic research into industrially relevant pharmaceutical processing research at the CPPR academic sites, with mentorship from representatives from CPPR companies.
